Is Esperion Therapeutics Worth $130? This Analyst Thinks So
March 27, 2015 at 18:17 PM EDT
In a report published Friday, Citi analysts initiated coverage Esperion Therapeutics Inc (NASDAQ: ESPR) with a Buy rating and a price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |